24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Garland graduated in 1988 from the University of Texas Health Science Center, and her residency was completed at the University of South Florida College of Medicine. Dr. Linda Garland finished her fellowship at the H. Lee Moffitt Cancer Center, and currently occupies the position of director for the Clinical Lung Cancer Program within the University of Arizona Cancer Center. Dr. Linda Garland is actively studying and researching mesothelioma for improving patient care.
University of Texas Health Science Center - 1988
Medical School
University of South Florida College of Medicine
Residency
H. Lee Moffitt Cancer Center
Fellowship
American Board of Internal Medicine - Oncology
University of Arizona Cancer Center
Languages: English/Spanish
(520) 694-2873
1515 N Campbell Ave
Tucson, Arizona 85724 
“Individualizing mesothelioma treatment: Small Steps into a Brighter Future”
Garland L., Flores F., Tsao A., Clinical Lung Cancer, Vol. 11, No. 6, 371-373.
See more >>
“A Phase II study of oral EGFR tyrosine kinase inhibitor erlotinib in patients with malignant pleural mesothelioma:
Garland L, Rankin C, Gandara D, Rivkin S, Scott K, Nagle R, Altomare D, Klein-Szanto A, Testa R, Borden E.A Southwest Oncology Group Stu
See more >>
“A Phase I Pharmacokinetic Study of HMN-214, a Novel Oral Stilbene Derivative With Polo-Like Kinase-1 Interacting Properties, in Patients With Advanced Solid Tumors.”
Garland L, Taylor C, Pilkington D, Cohen J, Von Hoff D.Clin Cancer Res
See more >>